|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's range||2.9700 - 2.9700|
|52-week range||2.9700 - 5.3900|
|Beta (5Y monthly)||1.04|
|PE ratio (TTM)||5.64|
|Forward dividend & yield||0.16 (5.52%)|
|Ex-dividend date||19 May 2022|
|1y target est||N/A|
The expansion will create 800 new retail jobs.
Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), today announced that it plans to report its first quarter 2022 financial results after market close on May 10, 2021. Liminal will host a conference call and webcast to discuss financial results at 8:30 am (ET) on Wednesday May 11, 2022.
Like-for-like sales rose more than 22% in Kingfisher's second half results.